MX9709982A - Retinoides de chalcona y uso de los mismos. - Google Patents

Retinoides de chalcona y uso de los mismos.

Info

Publication number
MX9709982A
MX9709982A MX9709982A MX9709982A MX9709982A MX 9709982 A MX9709982 A MX 9709982A MX 9709982 A MX9709982 A MX 9709982A MX 9709982 A MX9709982 A MX 9709982A MX 9709982 A MX9709982 A MX 9709982A
Authority
MX
Mexico
Prior art keywords
methods
same
chalcone
retinoids
chalcone retinoids
Prior art date
Application number
MX9709982A
Other languages
English (en)
Other versions
MXPA97009982A (es
Inventor
Rui Han
Zong-Ru Guo
Original Assignee
Inst Materia Medica
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Materia Medica filed Critical Inst Materia Medica
Publication of MX9709982A publication Critical patent/MX9709982A/es
Publication of MXPA97009982A publication Critical patent/MXPA97009982A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/24—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/25—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/56—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/84—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se proveen compuestos nuevos, como retinoides de chalcona y composiciones de los mismos, los cuales exhiben actividad terapéutica y/o biologica en células cancerígenas o pre-cancerígenas, así como al uso de los mismos.
MXPA/A/1997/009982A 1995-06-07 1997-12-08 Retinoides de chalcona y uso de los mismos MXPA97009982A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47557395A 1995-06-07 1995-06-07
US475573 1995-06-07

Publications (2)

Publication Number Publication Date
MX9709982A true MX9709982A (es) 1998-06-28
MXPA97009982A MXPA97009982A (es) 1998-10-30

Family

ID=

Also Published As

Publication number Publication date
WO1996040620A1 (en) 1996-12-19
AU702423B2 (en) 1999-02-18
AU6342396A (en) 1996-12-30
CA2223948A1 (en) 1996-12-19
JPH11511121A (ja) 1999-09-28
IL122341A0 (en) 1998-04-05
NZ311995A (en) 1999-03-29
EP0832060A1 (en) 1998-04-01

Similar Documents

Publication Publication Date Title
YU18799A (sh) Monociklični l-nukleozidi, njihovi analozi i njihova upotreba
AU3142195A (en) Dermatological compositions containing benzoyl peroxide and a compound reducing skin irritation
MY121548A (en) Compounds and methods for the treatment of cancer
AU5624699A (en) Use of 5ht-6 antagonists
IL143747A0 (en) Substituted aryl or heteroarylamides having retinoid-like biological activity
AU1373499A (en) Use of 9-deoxy-2', 9-alpha-methano-3- oxa-4,5,6- trinor-3, 7-(1',3'-interphenylene) -13,14-dihydro- prostaglandin f1 to treat peripheral vascular disease
IL112539A0 (en) Pyrimidine derivatives and their preparation
IL135921A (en) Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
UA29466C2 (uk) Фармацевтична композиція з антипухлинною активністю
AU5186799A (en) Peptides of il-2 and derivatives thereof and their use as therapeutic agents
BG102250A (en) The use of marigold-extracted glycosides for the treatment of psoriasis
CA2157836A1 (en) L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses
AU3474699A (en) Novel retinoids and use thereof
BG101126A (en) The use of muramylpeptide compounds
TR200002203T2 (tr) Lemfotoksin (LT) sentezlenme yolunun inhibitörleri kullanılarak foliküler lemfomaların tedavisi.
AU3076695A (en) Dinucleoside-5',5'-pyrophosphates
TR199900662T2 (xx) 1-Hidroksi-2-piridonlar�n seborik dermatit tedavisi amac�yla kullan�m�
MX9800049A (es) Antraquinonas mono- y disulfo-substituidas y su uso para el tratamiento de trastornos de la matriz del hueso.
MX9704948A (es) Retinoides triciclicos, metodos para su produccion y uso.
AU4202096A (en) The use of sertraline to treat cancer patients
MX9709982A (es) Retinoides de chalcona y uso de los mismos.
MX9709979A (es) Retinoides y metodos de uso de los mismos.
AU6722498A (en) Disubstituted biphenyloxazolines
DE69217221D1 (de) Hydrochinonderivate und diese enthaltende Antioxydantien sowie Tumorinhibitoren
AUPM493194A0 (en) Therapeutic agent for inhibiting the conversion of epithelial cells to tumours